BRAINSTORM CELL THERAPEUTICS INC. Increase (Decrease) in Employee Related Liabilities
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) reported Increase (Decrease) in Employee Related Liabilities of $412.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities · last filed 2025-05-15
- BRAINSTORM CELL THERAPEUTICS INC. increase (decrease) in employee related liabilities for the quarter ending 2025-03-31 was $412.00K.
- BRAINSTORM CELL THERAPEUTICS INC. increase (decrease) in employee related liabilities for the quarter ending 2024-03-31 was -$690.00K.
| Period end | Increase (Decrease) in Employee Related Liabilities 3 month |
|---|---|
| 2025-03-31 | $412.00K 10-Q · filed 2025-05-15 |
| 2024-03-31 | -$690.00K 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |